Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.39CNY
158.91 MCNY
619.55 MCNY
97.63 M
About GEMPHARMATECH
Sector
Industry
CEO
Jing Zhao
Website
Headquarters
Nanjing
Founded
2017
ISIN
CNE100005964
FIGI
BBG011YS3HQ8
GemPharmatech Co., Ltd. engages in research and development, manufacture, and sale of experimental mouse models. Its services include custom model generation, cell lines and customization, germ-gree and microbiome, preclinical testing, custom breeding, animal quality testing services. The company was founded by Xiang Gao on December 29, 2017 and is headquartered in Nanjing, China.
An aggregate view of professional's ratings.
Frequently Asked Questions
The current price of 688046 is 14.79 CNY — it has increased by 16.37% in the past 24 hours. Watch GEMPHARMATECH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange GEMPHARMATECH stocks are traded under the ticker 688046.
688046 stock has risen by 29.85% compared to the previous week, the month change is a 38.10% rise, over the last year GEMPHARMATECH has showed a −15.00% decrease.
We've gathered analysts' opinions on GEMPHARMATECH future price: according to them, 688046 price has a max estimate of 14.00 CNY and a min estimate of 14.00 CNY. Watch 688046 chart and read a more detailed GEMPHARMATECH stock forecast: see what analysts think of GEMPHARMATECH and suggest that you do with its stocks.
688046 reached its all-time high on Aug 23, 2022 with the price of 35.87 CNY, and its all-time low was 9.08 CNY and was reached on Jul 10, 2024. View more price dynamics on 688046 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
688046 stock is 18.94% volatile and has beta coefficient of 1.19. Track GEMPHARMATECH stock price on the chart and check out the list of the most volatile stocks — is GEMPHARMATECH there?
Today GEMPHARMATECH has the market capitalization of 6.04 B, it has increased by 0.53% over the last week.
Yes, you can track GEMPHARMATECH financials in yearly and quarterly reports right on TradingView.
GEMPHARMATECH is going to release the next earnings report on Oct 28, 2024. Keep track of upcoming events with our Earnings Calendar.
688046 net income for the last quarter is 46.86 M CNY, while the quarter before that showed 29.48 M CNY of net income which accounts for 58.95% change. Track more GEMPHARMATECH financial stats to get the full picture.
Yes, 688046 dividends are paid annually. The last dividend per share was 0.16 CNY. As of today, Dividend Yield (TTM)% is 1.08%. Tracking GEMPHARMATECH dividends might help you take more informed decisions.
GEMPHARMATECH dividend yield was 0.79% in 2023, and payout ratio reached 41.28%. The year before the numbers were 0.17% and 10.21% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 2, 2024, the company has 1.51 K employees. See our rating of the largest employees — is GEMPHARMATECH on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GEMPHARMATECH EBITDA is 180.73 M CNY, and current EBITDA margin is 27.98%. See more stats in GEMPHARMATECH financial statements.
Like other stocks, 688046 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GEMPHARMATECH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GEMPHARMATECH technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GEMPHARMATECH stock shows the neutral signal. See more of GEMPHARMATECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.